Australia - English - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - candesartan cilexetil, quantity: 4 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; carmellose calcium; magnesium stearate; hyprolose; macrogol 8000; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - candesartan cilexetil, quantity: 4 mg - tablet, uncoated - excipient ingredients: hyprolose; magnesium stearate; aluminium magnesium silicate; carmellose calcium; lactose monohydrate; propylene glycol - treatment of hypertension. treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction less than or equal to 40 percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - candesartan cilexetil, quantity: 4 mg - tablet - excipient ingredients: triacetin; lactose; hyprolose; magnesium stearate; carmellose calcium; maize starch - for the treatment of:,hypertension,patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction less than or equal to 40 percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - candesartan cilexetil, quantity: 32 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet - excipient ingredients: iron oxide yellow; lactose monohydrate; povidone; carrageenan; magnesium stearate; croscarmellose sodium; iron oxide red; iron oxide black; maize starch - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - candesartan cilexetil, quantity: 16 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet - excipient ingredients: magnesium stearate; carrageenan; maize starch; iron oxide red; croscarmellose sodium; povidone; iron oxide yellow; lactose monohydrate - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - candesartan cilexetil, quantity: 32 mg - tablet - excipient ingredients: maize starch; magnesium stearate; titanium dioxide; povidone; lactose monohydrate; iron oxide red; carrageenan; croscarmellose sodium - treatment of hypertension. . treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction less than or equal to 40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - candesartan cilexetil, quantity: 16 mg - tablet - excipient ingredients: magnesium stearate; maize starch; titanium dioxide; carrageenan; iron oxide red; povidone; croscarmellose sodium; lactose monohydrate - treatment of hypertension. . treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction less than or equal to 40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - candesartan cilexetil, quantity: 8 mg - tablet - excipient ingredients: lactose monohydrate; carrageenan; maize starch; povidone; iron oxide red; croscarmellose sodium; titanium dioxide; magnesium stearate - treatment of hypertension. . treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction less than or equal to 40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - candesartan cilexetil, quantity: 16 mg - tablet, uncoated - excipient ingredients: maize starch; carmellose calcium; magnesium stearate; hyprolose; lactose monohydrate; macrogol 8000; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - candesartan cilexetil, quantity: 8 mg - tablet, uncoated - excipient ingredients: hyprolose; lactose monohydrate; macrogol 8000; carmellose calcium; maize starch; magnesium stearate; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.